Q&A With Greg Rotz, PLS Advisory Leader at PwC
PharmExec
SEPTEMBER 14, 2022
Rotz discusses a report he co-authored for PwC about how life sciences companies perform on the S&P 500.
authors pwc 
52 
How to Measure Sales Coaching Effectiveness in Pharma
Quantified
OCTOBER 31, 2022
In its “Pharmaceuticals & Life Sciences: Deals 2022 Midyear Outlook, PwC says , “Deal activity in the pharma space is down by 30% on a semi-annualized basis. For instance, PwC says pharma companies are re-examining capital allocation strategies and designing more resilient supply chains. But what about the field force?
Let's personalize your content